• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Antibody conjugated nano and microparticle systems for targeted immunosuppression and purification of extracellular vesicles

    Haycook, Christopher Paul
    0000-0002-3974-2613
    : http://hdl.handle.net/1803/16940
    : 2021-10-13

    Abstract

    Helper T cell activity is dysregulated in a number of diseases with limited treatment options, including those associated with rheumatic autoimmunity. Phosphodiesterase 4 (PDE4) inhibition has the potential to enable controlled immunosuppression, but a targeted therapy has not yet been developed to leverage this opportunity. Inappropriate activation of the epidermal growth factor receptor (EGFR) is a driver of tumorigenesis in many cancers, such as colorectal cancer (CRC). The activation status of EGFR is reflected in subpopulations of extracellular vesicles (EVs) originating from cancer cells. However, current laboratory-based EV purification techniques are labor intensive and inefficient. This research addresses challenges in two distinct areas that are unified through the implementation of antibody conjugates that provide novel solutions for each challenge. The overall goals of this work are to enable both targeted immunosuppression of CD4+ T cells and the purification of EGFR+ cancer associated EVs. In this work we employed maleimide-thiol mediated conjugation of anti-CD4 F(ab’) antibody fragments to enable nanoparticle targeted delivery of Eggmanone, a specific PDE4 inhibitor, to CD4+ T cells. We also developed cetuximab-DNA conjugates with cleavable DNA linkers containing two unique restriction sites flanking a fluorescently modified residue to provide selective labeling of EGFR+ EVs purified with superparamagnetic microparticles. Our novel delivery system targeted the majority of CD4+ T cells present among a complex cell population, and we have demonstrated antigen specific inhibition of CD4+ T cell responses mediated by nanoparticle formulated Egm. Cetuximab decorated, superparamagnetic microparticles enabled the purification of EGFR+ EVs from conditioned media, and we demonstrated non-destructive release and fluorescent labeling of purified EVs. This work is the first characterization of Egm’s immunomodulatory potential, and it suggests the potential benefit of a biodegradable delivery vehicle that is designed for targeted immunosuppression. It is also the first characterization of a restriction enzyme cleavable antibody conjugate linker that enables non-destructive release of captured EVs and demonstrates the benefit of selective fluorescent labeling of purified EVs that could improve downstream analysis.
    Show full item record

    Files in this item

    Icon
    Name:
    HAYCOOK-DISSERTATION-2021.pdf
    Size:
    4.427Mb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy